 |
|
|
|
|
|
Name: |
|
Joann Ater MD |
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
Facility: |
|
MD Anderson Cancer Center |
|
|
|
|
|
|
Location: |
|
Houston, TX USA |
|
|
|
|
Phone: |
|
713-792-6665 |
|
|
|
|
|
|
Fax: |
|
|
|
|
|
|
Email: |
|
Click here to send an email |
|
|
|
|
|
|
Website: |
|
|
|
|
|
|
|
|
|
Name: |
|
John F. de Groot MD |
|
|
|
|
Title: |
|
Department of Neuro-Oncology |
|
|
|
|
|
|
Facility: |
|
MD Anderson Cancer Center |
|
|
|
|
|
|
Location: |
|
Contact: Be Pei, Department of Neuro Oncology - Unit 431
1515 Holcombe Blvd
Houston, TX USA |
|
|
|
|
Phone: |
|
713-792-8560 |
|
|
|
|
|
|
Fax: |
|
|
|
|
|
|
Email: |
|
Click here to send an email |
|
|
|
|
|
|
Website: |
|
|
|
|
|
|
|
|
|
Name: |
|
Morris D. Groves MD |
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
Facility: |
|
MD Anderson Cancer Center |
|
|
|
|
|
|
Location: |
|
Houston, TX USA |
|
|
|
|
Phone: |
|
713-792-6600 |
|
|
|
|
|
|
Fax: |
|
|
|
|
|
|
Email: |
|
Email not available |
|
|
|
|
|
|
Website: |
|
|
|
|
|
|
|
|
|
Name: |
|
Sigmund Hsu MD |
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
Facility: |
|
MD Anderson Cancer Center |
|
|
|
|
|
|
Location: |
|
Houston, TX USA |
|
|
|
|
Phone: |
|
713-792-2573 |
|
|
|
|
|
|
Fax: |
|
|
|
|
|
|
Email: |
|
Click here to send an email |
|
|
|
|
|
|
Website: |
|
|
|
|
|
|
|
|
|
Name: |
|
Wai-Kwan Alfred Yung MD |
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
Facility: |
|
MD Anderson Cancer Center |
|
|
|
|
|
|
Location: |
|
U. Of Texas
Houston, TX USA |
|
|
|
|
Phone: |
|
713-794-1285 |
|
|
|
|
|
|
Fax: |
|
|
|
|
|
|
Email: |
|
Email not available |
|
|
|
|
|
|
Website: |
|
www.mdanderson.org/diseases/braincancer/ |
|
|
There are 33 listings:
|
|
|
|
|
|
Treatment Next 25
|
|
Location |
|
Last Updated |
|
|
|
Details |
|
RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
04/13/2010 |
|
|
|
|
|
Details |
|
2009-0476: A Phase I dose-finding study of XL184 administered orally in combination with Temozolomide and Radiation Therapy in first line treatment of glioblastoma |
|
Houston, TX |
|
03/30/2010 |
|
|
|
Details |
|
2007-0816: Phase 2 Study of XL184 in Subjects with Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse |
|
Houston, TX |
|
03/30/2010 |
|
|
|
|
|
Details |
|
2006-0709: Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX |
|
03/30/2010 |
|
|
|
Details |
|
2009-0548: A Phase I Study of MK-0752, a Notch Inhibitor, in Patients With recurrent glioma |
|
Houston, TX |
|
03/30/2010 |
|
|
|
|
|
Details |
|
2009-0597: Randomized Phase II Trial of Standard Dose Bevacizumab Versus Low Dose Bevacizumab plus Lomustine (CCNU) In Adults with Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
03/30/2010 |
|
|
|
Details |
|
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
|
Houston, TX |
|
03/30/2010 |
|
|
|
|
|
Details |
|
2004-0662: Randomized, factorial-design, Phase II trial of Temozolomide alone and in combination with possible permutations of Thalidomide, Isotretinoin and/or Celecoxib as post-radiation adjuvant therapy of glioblastoma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
BTTC08-01: Phase II Post-RT/TMZ Bevacizumab and Erlotinib for newly GBM without MGMT promoter methylation |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
NABTC04-03: Phase I study of Vorinostat (SAHA) in combination with temozolomide in patiesnts with malignant gliomas |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
2009-0576: Phase I evaluation of SCH900105 with correlative tissue studies in the treatment of adult patients with recurrent glioblastoma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
2009-0651: Phase I/II adaptive randomized trial of vorinostat, erlotinib and carboplatin in adults with recurrent glioblastoma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
NABTC0701: Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
2007-0491: Phase 2, 2-part, multicenter, open-label study to evaluate the safety, tolerability, and efficacy of CT-322 (Angiocept™) monotherapy and combination therapy with irinotecan in patients with recurrent glioblastoma multiforme
|
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
2006-0472: Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
2008-0059: Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
2007-0532: Phase III double blind, placebo controlled study of donepezil in irradiated brain tumor patients |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
ID01-310: Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
2008-0318: Phase I/II trial of Dasatinib (Sprycel) with Radiation Therapy and concomitant and Adjuvant Temozolomide in Patients with newly diagnosed Glioblastoma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
Houston, TX |
|
03/09/2010 |
|
|
|
Details |
|
Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma |
|
Houston, TX |
|
01/03/2010 |
|
|
|
|
|
Details |
|
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
|
|
Houston, TX |
|
10/09/2008 |
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
Houston, TX |
|
10/03/2007 |
|
|
|
|
|
Details |
|
Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme |
|
Houston, TX |
|
08/18/2007 |
|
|
|
Details |
|
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma |
|
Houston, TX |
|
08/04/2007 |
|
|
|
|
|
|
|
